Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,766 | 215 | 94.2% |
| Education | $290.84 | 11 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $822.45 | 22 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $627.73 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $525.62 | 29 | $0 (2024) |
| Vifor Pharma, Inc. | $439.75 | 19 | $0 (2023) |
| Amgen Inc. | $364.46 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $331.33 | 18 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $190.70 | 10 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $174.95 | 10 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $170.55 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $162.31 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $587.77 | 29 | Novartis Pharmaceuticals Corporation ($98.28) |
| 2023 | $719.92 | 31 | Vifor Pharma, Inc. ($171.54) |
| 2022 | $809.46 | 41 | Vifor Pharma, Inc. ($242.84) |
| 2021 | $543.75 | 31 | AKEBIA THERAPEUTICS INC ($142.34) |
| 2020 | $510.36 | 28 | AstraZeneca Pharmaceuticals LP ($103.92) |
| 2019 | $569.16 | 23 | AKEBIA THERAPEUTICS INC ($134.39) |
| 2018 | $574.36 | 26 | NxStage Medical, Inc. ($128.97) |
| 2017 | $742.00 | 17 | Fresenius USA Marketing, Inc. ($533.74) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/02/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Nephrology | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 08/13/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEPHROLOGY | ||||||
| 08/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2024 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Renal | ||||||
| 07/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.00 | General |
| 05/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Cardio-renal | ||||||
| 05/22/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Nephrology | ||||||
| 05/16/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.80 | General |
| 05/02/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.83 | General |
| Category: NEPHROLOGY | ||||||
| 04/09/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Nephrology | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: DIABETES | ||||||
| 03/25/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Nephrology | ||||||
| 02/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DIABETES | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: NEPHROLOGY | ||||||
| 01/23/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.54 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,420 | 2,730 | $738,572 | $210,152 |
| 2022 | 21 | 1,819 | 3,860 | $931,435 | $264,379 |
| 2021 | 18 | 2,221 | 4,188 | $996,521 | $298,197 |
| 2020 | 18 | 2,256 | 4,285 | $1.3M | $337,524 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 65 | 412 | $420,240 | $107,534 | 25.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 39 | 80 | $68,880 | $16,645 | 24.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 83 | 103 | $30,900 | $13,015 | 42.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 134 | $20,234 | $11,840 | 58.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 184 | $19,504 | $10,669 | 54.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 89 | 201 | $53,466 | $10,584 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 182 | $27,664 | $9,333 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 55 | 55 | $17,765 | $7,364 | 41.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 18 | 151 | $7,550 | $5,247 | 69.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 18 | 144 | $5,760 | $4,128 | 71.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 85 | $4,420 | $2,828 | 64.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 12 | 16 | $13,056 | $2,429 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 53 | $5,141 | $2,381 | 46.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 129 | 172 | $19,264 | $1,754 | 9.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 128 | 184 | $1,840 | $1,515 | 82.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 130 | 180 | $14,220 | $1,350 | 9.5% |
| 84100 | Phosphate level | Office | 2023 | 129 | 169 | $3,718 | $774.37 | 20.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 165 | 225 | $4,950 | $761.14 | 15.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 69 | 388 | $395,760 | $101,663 | 25.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 70 | 136 | $117,096 | $30,237 | 25.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 18 | 97 | $83,808 | $22,086 | 26.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 120 | 139 | $41,700 | $19,551 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 275 | $41,800 | $14,793 | 35.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 125 | 269 | $71,554 | $14,249 | 19.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 120 | 233 | $24,698 | $11,980 | 48.5% |
About Christopher Miller
Christopher Miller is a Nephrology healthcare provider based in Tupelo, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780654632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Miller has received a total of $5,057 in payments from pharmaceutical and medical device companies, with $587.77 received in 2024. These payments were reported across 226 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,766).
As a Medicare-enrolled provider, Miller has provided services to 7,716 Medicare beneficiaries, totaling 15,063 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Tupelo, MS
- Active Since 01/24/2006
- Last Updated 06/30/2008
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1780654632
Products in Payments
- Not Product Related (Medical Supply) $481.83
- Auryxia (Drug) $420.88
- Veltassa (Drug) $313.62
- ACTHAR (Biological) $304.48
- LOKELMA (Drug) $278.61
- JYNARQUE (Drug) $259.80
- Velphoro (Drug) $259.10
- FARXIGA (Drug) $210.85
- AURYXIA (Drug) $206.85
- Kerendia (Drug) $190.70
- RAYALDEE (Drug) $174.95
- Parsabiv (Drug) $154.88
- System One (Device) $128.97
- Parsabiv (Biological) $120.18
- BENLYSTA (Biological) $110.10
- SAMSCA (Drug) $92.16
- Ensite Cardiac Mapping System (Device) $82.10
- PURIFIED CORTROPHIN GEL (Drug) $78.52
- Korsuva (Drug) $67.34
- LUPKYNIS (Drug) $57.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Tupelo
Thomas Wooldridge, Md, MD
Nephrology — Payments: $15,994
Dr. Marcus Britton, M.d, M.D
Nephrology — Payments: $7,744
Morris Hamilton, Md, MD
Nephrology — Payments: $6,265
John Lee, Md, MD
Nephrology — Payments: $5,824
Tzonko Milev, Md, MD
Nephrology — Payments: $4,673
John Elliott, D.o, D.O
Nephrology — Payments: $4,032